Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy.

Bundred NJ, Kenemans P, Yip CH, Beckmann MW, Foidart JM, Sismondi P, Schoultz Bv, Vassilopoulou-Sellin R, Galta RE, Lieshout EV, Mol-Arts M, Planellas J, Kubista E.

Breast Cancer Res. 2012 Jan 17;14(1):R13.

2.

[Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].

Reginster JY.

J Gynecol Obstet Biol Reprod (Paris). 2002 Oct;31(6):541-9. Review. French.

3.

Short and long term effects of tibolone in postmenopausal women.

Formoso G, Perrone E, Maltoni S, Balduzzi S, D'Amico R, Bassi C, Basevi V, Marata AM, Magrini N, Maestri E.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008536. doi: 10.1002/14651858.CD008536.pub2. Review. Update in: Cochrane Database Syst Rev. 2016 Oct 12;10 :CD008536.

PMID:
22336846
4.

Add-back therapy with GnRH analogues for uterine fibroids.

Moroni RM, Martins WP, Ferriani RA, Vieira CS, Nastri CO, Candido Dos Reis FJ, Brito LG.

Cochrane Database Syst Rev. 2015 Mar 20;(3):CD010854. doi: 10.1002/14651858.CD010854.pub2. Review.

PMID:
25793972
5.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326.

PMID:
16856092

Supplemental Content

Support Center